BMC Cancer (ISSN 1471-2407) is an online journal publishing
research articles after full peer review. All articles are published, without barriers to access, immediately upon acceptance. The journal is published by BioMed Central Ltd, Middlesex House, 34-42 Cleveland Street, London W1T 4LB, UK.
Scope
BMC Cancer is an Open Access, peer-reviewed journal that considers articles on all aspects of research relating to cancer, including molecular biology,
genetics, pathophysiology, epidemiology, clinical reports, and controlled trials.
Criteria for publication
Publication of research articles by BMC Cancer is dependent primarily on their validity and coherence
, as judged by peer reviewers, who are also asked whether the writing is comprehensible and how interesting they consider the article to be. If an article is of broad interest, the authors may be asked if they would prefer it to be published in BMC Medicine, and the article may be highlighted in a variety of ways as a service to our readers and contributors.
Speed of publication
BMC Cancer offers
a very fast publication schedule while
maintaining rigorous peer review;
all articles must be submitted online, and peer review is managed fully electronically (articles are distributed
in PDF form, which is automatically generated from the submitted files). Articles will be published electronically
in manuscript form immediately upon acceptance. A fully structured web version, and accompanying laid out PDF,
will be published within a few weeks of acceptance.
Flexibility
As an electronic-only journal, BMC Cancer gives authors the opportunity to publish
large data sets, large numbers of
illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other papers).
Submission of manuscripts
Manuscripts must be submitted to BMC Cancer electronically using
the online submission system. Full details
of how to submit a manuscript are given in the instructions for authors.
Indexing and archiving Following publication in BMC Cancer, the full text of each article is immediately and permanently archived in PubMed Central, the US National Library of Medicine's full-text repository of life science literature, and also in repositories at the University of Potsdam in Germany, at INIST in France and in e-Depot, the National Library of the Netherlands' digital archive of all electronic publications. BMC Cancer is indexed/tracked/covered by PubMed, MEDLINE, CAS, Scopus, EMBASE, Current Contents and Google Scholar.
BMC Cancer is included in Thomson Reuters Web of Science and other products.
It has an Impact Factor of 2.71.
Copyright
The authors are the copyright holders for all articles in BMC Cancer and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the article, according to the BioMed Central copyright and license rules.
Citing papers in the journal
Articles in BMC Cancer should be cited in the same way
as articles in a traditional journal, with one exception. Because articles in this journal are not printed, they do not have page numbers. Instead, they have a unique article number.
The following citation:
BMC Cancer 2000, 1:2
refers to article 2 from volume 1 of the journal.
As an online journal, BMC Cancer does not have issue numbers.
Each volume corresponds to a calendar year.
Contacting BMC Cancer
Queries about content, submissions, or the review process should be directed to
editorial@biomedcentral.com.
All other enquiries should be directed to info@biomedcentral.com.
|